GPX4 and acute myeloid leukemia: Likewise, GNPIPP12MA nanoparticles, designed to lower GSH levels and disrupt GPX4 function, effectively target m6A mRNA hypermethylation, decreasing mRNA transcript stability in AML cells [78].